Needles

Global Needles Market to Reach US$11.4 Billion by 2030

The global market for Needles estimated at US$8.5 Billion in the year 2024, is expected to reach US$11.4 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Conventional Needles, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$6.6 Billion by the end of the analysis period. Growth in the Safety Needles segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.1% CAGR

The Needles market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Needles Market - Key Trends & Drivers Summarized

What Are Medical Needles, and Why Are They Integral to Healthcare?
Medical needles are essential tools used for a wide range of medical applications, including injections, blood sampling, and fluid administration. They are a critical component of syringes, IV catheters, and other delivery systems, making them indispensable in hospitals, clinics, and home healthcare. Needles are available in various sizes, gauges, and types depending on the specific medical procedure, ranging from simple hypodermic needles for vaccinations to specialized needles for biopsy or spinal procedures. With their widespread use in administering medications and collecting biological samples, medical needles are a cornerstone of modern healthcare delivery.

How Are Medical Needles Evolving to Enhance Patient Safety and Comfort?
The design and technology of medical needles have significantly evolved to enhance patient safety and comfort. One of the most important advancements is the development of safety needles with retractable or shielded mechanisms to reduce the risk of needlestick injuries to healthcare workers. These innovations are particularly crucial in reducing the transmission of bloodborne pathogens in medical settings. Additionally, needles are being designed to minimize pain and discomfort during procedures, with ultra-thin and short-length needles becoming more common in vaccines and insulin administration. In oncology and other specialized treatments, hollow and beveled needles are improving the accuracy and effectiveness of drug delivery, ensuring that treatments reach the intended target areas with precision.

What Trends Are Shaping the Medical Needles Market?
Several trends are influencing the medical needles market, including the increasing adoption of safety needles driven by stricter regulations aimed at reducing needlestick injuries. Government bodies in regions like North America and Europe are enforcing the use of safety-engineered devices, boosting demand for advanced needle technologies. Another trend is the growing use of needles in home healthcare, where patients with chronic conditions, such as diabetes, require frequent self-administration of medications like insulin. The rise in minimally invasive procedures is also contributing to market growth, as these treatments rely heavily on needles for accurate drug delivery and diagnostic testing. Additionally, the global vaccination efforts, especially in light of the COVID-19 pandemic, have significantly increased the demand for hypodermic needles.

What Factors Are Driving the Growth of the Medical Needles Market?
The growth in the medical needles market is driven by several factors, including the increasing prevalence of chronic diseases, rising demand for vaccinations, and advancements in needle technology. The global rise in diabetes and other chronic conditions that require regular injections is a major driver of needle demand. The ongoing efforts to vaccinate populations, particularly with global initiatives to combat pandemics like COVID-19, have also surged the demand for hypodermic needles. Furthermore, advancements in safety mechanisms, such as retractable needles and needle shields, are encouraging adoption among healthcare providers focused on reducing needlestick injuries. The trend toward home-based care is further accelerating the need for needles that are easy to use for patients managing chronic conditions at home. Lastly, the growing use of needles in diagnostic and minimally invasive procedures is contributing to market expansion across healthcare sectors.

SCOPE OF STUDY:

The report analyzes the Needles market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Conventional Needles, Safety Needles); Delivery Mode (Hypodermic, Intravenous, Intramuscular, Intraperitoneal); End-Use (Hospitals, Diagnostic Centers, Home Healthcare, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 86 Featured) -

• B. Braun Melsungen AG
• Becton, Dickinson & Company
• Boston Scientific Corporation
• Ethicon US LLC
• Hamilton Company
• Medtronic PLC
• Nipro Corporation
• Novo Nordisk A/S
• Olympus Corporation
• Smiths Medical
• Stryker Corporation
• Terumo Corporation
• Thermo Fisher Scientific, Inc.
• Unimed SA

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.